Catalyst Pharmaceutical (CPRX) PT Lowered to $6 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Charles Duncan cut his price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $6.00 (from $10.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
